200 related articles for article (PubMed ID: 15126158)
1. Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfin-photodynamic therapy.
Grisanti S; Tatar O; Canbek S; Lafaut BA; Gelisken F; Inhoffen W; Szurman P; Aisenbrey S; Oficjalska-Mlynczak J; Bartz-Schmidt KU
Am J Ophthalmol; 2004 May; 137(5):914-23. PubMed ID: 15126158
[TBL] [Abstract][Full Text] [Related]
2. Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.
Tatar O; Kaiserling E; Adam A; Gelisken F; Shinoda K; Völker M; Lafaut BA; Bartz-Schmidt KU; Grisanti S
Arch Ophthalmol; 2006 Jun; 124(6):815-23. PubMed ID: 16769835
[TBL] [Abstract][Full Text] [Related]
3. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.
Tatar O; Adam A; Shinoda K; Stalmans P; Eckardt C; Lüke M; Bartz-Schmidt KU; Grisanti S
Am J Ophthalmol; 2006 Jul; 142(1):95-104. PubMed ID: 16815256
[TBL] [Abstract][Full Text] [Related]
4. Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degeneration.
Tatar O; Adam A; Shinoda K; Yoeruek E; Szurman P; Bopp S; Eckardt C; Bartz-Schmidt KU; Grisanti S
Retina; 2007; 27(6):713-23. PubMed ID: 17621180
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.
Moshfeghi DM; Kaiser PK; Grossniklaus HE; Sternberg P; Sears JE; Johnson MW; Ratliff N; Branco A; Blumenkranz MS; Lewis H
Am J Ophthalmol; 2003 Mar; 135(3):343-50. PubMed ID: 12614752
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
[TBL] [Abstract][Full Text] [Related]
7. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
Schmidt-Erfurth UM; Michels S
Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
[TBL] [Abstract][Full Text] [Related]
8. Time course and morphology of vascular effects associated with photodynamic therapy.
Schmidt-Erfurth U; Niemeyer M; Geitzenauer W; Michels S
Ophthalmology; 2005 Dec; 112(12):2061-9. PubMed ID: 16325705
[TBL] [Abstract][Full Text] [Related]
9. Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes.
Petermeier K; Tatar O; Inhoffen W; Völker M; Lafaut BA; Henke-Fahle S; Gelisken F; Ziemssen F; Bopp S; Bartz-Schmidt KU; Grisanti S
Br J Ophthalmol; 2006 Aug; 90(8):1034-9. PubMed ID: 16613924
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy.
Ghazi NG; Jabbour NM; De La Cruz ZC; Green WR
Retina; 2001; 21(5):478-86. PubMed ID: 11642377
[TBL] [Abstract][Full Text] [Related]
12. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA
Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy.
Gelisken F; Lafaut BA; Inhoffen W; Voelker M; Grisanti S; Bartz-Schmidt KU
Br J Ophthalmol; 2004 Feb; 88(2):207-11. PubMed ID: 14736776
[TBL] [Abstract][Full Text] [Related]
14. Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.
Tatar O; Shinoda K; Adam A; Eckert T; Eckardt C; Lucke K; Deuter C; Bartz-Schmidt KU; Grisanti S
Br J Ophthalmol; 2007 Feb; 91(2):166-73. PubMed ID: 16987895
[TBL] [Abstract][Full Text] [Related]
15. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
Hariprasad SM; Shah GK
Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
[TBL] [Abstract][Full Text] [Related]
16. Choroidal neovascular membranes treated with photodynamic therapy.
Arroyo JG; Michaud N; Jakobiec FA
Arch Ophthalmol; 2003 Jun; 121(6):898-903. PubMed ID: 12796267
[No Abstract] [Full Text] [Related]
17. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
18. Choroidal neovascular membranes after photodynamic therapy: ultrastructural analysis of two surgically excised membranes.
Gremigni E; Falleni A; Belting C; Di Bartolo E; Rizzo S
Eur J Ophthalmol; 2004; 14(6):555-61. PubMed ID: 15638107
[TBL] [Abstract][Full Text] [Related]
19. Sequence of early vascular events after photodynamic therapy.
Michels S; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin photodynamic therapy involving the optic nerve for peripapillary choroidal neovascularization.
Bernstein PS; Horn RS
Retina; 2008 Jan; 28(1):81-4. PubMed ID: 18185142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
